Becton, Dickinson and Co.

BDX

Becton, Dickinson and Co. (BDX) is a global medical technology company specializing in the development and manufacturing of medical devices, supplies, and laboratory equipment. Founded in 1897, it is known for its innovations in healthcare including syringes, safety-engineered devices, and diagnostic products, serving healthcare institutions, life sciences, and general medical markets worldwide.

$193.96 +0.20 (0.10%)
Dividend Yield 2.15%
Payout Frequency Quarterly

Dividend History

🎉 Upcoming Dividend

Investors can expect a dividend payout of $1.05 per share, scheduled to be distributed in 23 days on December 31, 2025

Pay DateAmountEx-DateRecord Date
December 31, 2025$1.052025-12-082025-12-08
September 30, 2025$1.042025-09-082025-09-08
June 30, 2025$1.042025-06-092025-06-09
March 31, 2025$1.042025-03-102025-03-10
December 31, 2024$1.042024-12-092024-12-09

Dividends Summary

Company News

Europe Glass Prefilled Syringes and Glass Vials Packaging Equipment Market Trends 2035
GlobeNewswire Inc. • Towards Packaging • December 1, 2025

The European market for glass prefilled syringes and glass vials packaging equipment is projected to grow from USD 283.30 billion in 2025 to USD 389.13 billion by 2034, driven by rising demand for injectable biologics, sterile drug delivery systems, and advanced healthcare infrastructure.

Got $1,000? Here Are the Smartest Dividend Stocks to Start With.
The Motley Fool • Matthew Benjamin • November 10, 2025

With market valuations high and potential corrections likely, the article recommends eight defensive dividend stocks across consumer staples, healthcare, and utility sectors that have consistently increased dividends for over 50 years.

BD CFO Set To Exit Company This December, Stock Falls
Benzinga • Vandana Singh • October 16, 2025

Becton Dickinson announced CFO Chris DelOrefice will depart in December, with Vitor Roque named interim CFO. The company reported Q4 preliminary revenue of $5.9 billion and fiscal 2025 sales of $21.8 billion, slightly below consensus expectations.

Reasons to Add The Cooper Companies (COO) to Your Portfolio Now - Zacks Investment Research
Zacks Investment Research • Zacks Equity Research • July 24, 2024

The Cooper Companies is well-positioned for growth, driven by strong prospects in its CooperVision and CooperSurgical business segments. However, unfavorable currency movements and rising costs continue to impact revenues and margins.

Becton, Dickinson And Polaris: The Market Is Dead Wrong About These Dividend Aristocrat Bargains
Seeking Alpha • Dividend Sensei • June 1, 2024

Dividend aristocrats like Becton, Dickinson and Polaris are trading at 52-week lows. Read why these stocks present potentially attractive buying opportunities.

Related Companies